BI
LXRX icon

BVF Inc’s Lexicon Pharmaceuticals LXRX Stock Holding History

BVF Inc’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,686,924
Closed -$4.05M – 65
2024
Q1 		$4.05M Sell
1,686,924
-22,748,708
-93% -$48.9M 0.11% 50
2023
Q4 		$37.4M Buy
24,435,632
+4,440,300
+22% +$5.28M 0.94% 28
2023
Q3 		$21.8M Hold
19,995,332
– – 0.59% 33
2023
Q2 		$45.8M Buy
19,995,332
+3,846,153
+24% +$10.2M 1.28% 23
2023
Q1 		$39.2M Hold
16,149,179
– – 1.43% 23
2022
Q4 		$30.8M Hold
16,149,179
– – 1.3% 28
2022
Q3 		$38.8M Buy
16,149,179
+2,000,000
+14% +$5.54M 1.6% 22
2022
Q2 		$26.3M Sell
14,149,179
-207,410
-1% -$396K 1.27% 27
2022
Q1 		$30M Sell
14,356,589
-3,411
-0% -$9.46K 1.2% 26
2021
Q4 		$56.6M Hold
14,360,000
– – 2.05% 15
2021
Q3 		$69.1M Buy
14,360,000
+5,966,000
+71% +$24.5M 2.82% 10
2021
Q2 		$38.5M Hold
8,394,000
– – 1.44% 17
2021
Q1 		$49.3M Sell
8,394,000
-2,569,000
-23% -$17.8M 1.85% 17
2020
Q4 		$37.5M Buy
+10,963,000
New +$20.9M 1.48% 23

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return